UniProt ID | SIR2_HUMAN | |
---|---|---|
UniProt AC | Q8IXJ6 | |
Protein Name | NAD-dependent protein deacetylase sirtuin-2 | |
Gene Name | SIRT2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 389 | |
Subcellular Localization | Nucleus. Cytoplasm, perinuclear region. Cytoplasm. Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole. Cytoplasm, cytoskeleton, spindle | |
Protein Description | NAD-dependent protein deacetylase, which deacetylates internal lysines on histone and alpha-tubulin as well as many other proteins such as key transcription factors. [PubMed: 24177535] | |
Protein Sequence | MAEPDPSHPLETQAGKVQEAQDSDSDSEGGAAGGEADMDFLRNLFSQTLSLGSQKERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQSGAGVPNPSTSASPKKSPPPAKDEARTTEREKPQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAEPDPSHP ------CCCCCCCCC | 36.71 | 19413330 | |
18 (in isoform 2) | Ubiquitination | - | 43.74 | 21890473 | |
23 | Phosphorylation | KVQEAQDSDSDSEGG CCCCCCCCCCCCCCC | 27.25 | 30278072 | |
25 | Phosphorylation | QEAQDSDSDSEGGAA CCCCCCCCCCCCCCC | 47.16 | 30278072 | |
27 | Phosphorylation | AQDSDSDSEGGAAGG CCCCCCCCCCCCCCC | 41.93 | 26055452 | |
35 (in isoform 3) | Ubiquitination | - | 40.35 | 21890473 | |
46 | Phosphorylation | DFLRNLFSQTLSLGS HHHHHHHHCHHCCCC | 25.97 | 24076635 | |
48 | Phosphorylation | LRNLFSQTLSLGSQK HHHHHHCHHCCCCHH | 19.67 | 24076635 | |
50 | Phosphorylation | NLFSQTLSLGSQKER HHHHCHHCCCCHHHH | 33.79 | 24076635 | |
53 | Phosphorylation | SQTLSLGSQKERLLD HCHHCCCCHHHHHHH | 43.29 | 25307156 | |
55 (in isoform 4) | Ubiquitination | - | 46.64 | 21890473 | |
55 (in isoform 1) | Ubiquitination | - | 46.64 | 21890473 | |
55 | Ubiquitination | TLSLGSQKERLLDEL HHCCCCHHHHHHHHH | 46.64 | 2189047 | |
100 | Phosphorylation | IPDFRSPSTGLYDNL CCCCCCCCCCCCCCH | 36.03 | 24076635 | |
101 | Phosphorylation | PDFRSPSTGLYDNLE CCCCCCCCCCCCCHH | 34.29 | 29978859 | |
104 | Phosphorylation | RSPSTGLYDNLEKYH CCCCCCCCCCHHHCC | 12.25 | 28796482 | |
121 (in isoform 2) | Ubiquitination | - | 2.55 | 21890473 | |
126 | Ubiquitination | FEISYFKKHPEPFFA HHHHHHHHCCCCCHH | 55.27 | - | |
138 (in isoform 3) | Ubiquitination | - | 6.52 | 21890473 | |
158 (in isoform 4) | Ubiquitination | - | 50.28 | 21890473 | |
158 (in isoform 1) | Ubiquitination | - | 50.28 | 21890473 | |
158 | Ubiquitination | FMRLLKDKGLLLRCY HHHHHHHCCHHHHHH | 50.28 | - | |
189 | Phosphorylation | DLVEAHGTFYTSHCV HHHHHCCEEEEHHCC | 12.00 | 23898821 | |
191 | Phosphorylation | VEAHGTFYTSHCVSA HHHCCEEEEHHCCCH | 13.73 | 23898821 | |
192 | Phosphorylation | EAHGTFYTSHCVSAS HHCCEEEEHHCCCHH | 14.06 | 23898821 | |
193 | Phosphorylation | AHGTFYTSHCVSASC HCCEEEEHHCCCHHH | 11.96 | 23898821 | |
197 | Phosphorylation | FYTSHCVSASCRHEY EEEHHCCCHHHCCCC | 21.62 | 23898821 | |
199 | Phosphorylation | TSHCVSASCRHEYPL EHHCCCHHHCCCCCC | 12.27 | 23898821 | |
204 | Phosphorylation | SASCRHEYPLSWMKE CHHHCCCCCCHHHHH | 11.89 | 23898821 | |
207 | Phosphorylation | CRHEYPLSWMKEKIF HCCCCCCHHHHHHHH | 22.18 | 23898821 | |
212 | Ubiquitination | PLSWMKEKIFSEVTP CCHHHHHHHHHCCCC | 43.46 | - | |
215 | Phosphorylation | WMKEKIFSEVTPKCE HHHHHHHHCCCCCCH | 34.33 | 26270265 | |
218 | Phosphorylation | EKIFSEVTPKCEDCQ HHHHHCCCCCCHHHH | 16.99 | 26270265 | |
226 | Phosphorylation | PKCEDCQSLVKPDIV CCCHHHHHHCCCCEE | 41.27 | 26270265 | |
238 | Phosphorylation | DIVFFGESLPARFFS CEEEECCCCCHHHHH | 39.78 | 24719451 | |
271 | Phosphorylation | LQVQPFASLISKAPL CCHHCCHHHHHCCCC | 26.98 | 24719451 | |
274 | Phosphorylation | QPFASLISKAPLSTP HCCHHHHHCCCCCCC | 28.23 | - | |
279 | Phosphorylation | LISKAPLSTPRLLIN HHHCCCCCCCEEECC | 34.99 | 29449344 | |
280 | Phosphorylation | ISKAPLSTPRLLINK HHCCCCCCCEEECCH | 21.80 | 29449344 | |
287 | Ubiquitination | TPRLLINKEKAGQSD CCEEECCHHHCCCCC | 54.31 | - | |
311 | Phosphorylation | GGGMDFDSKKAYRDV CCCCCCCCHHHHCCC | 35.73 | 30387612 | |
316 | Methylation | FDSKKAYRDVAWLGE CCCHHHHCCCHHHCC | 36.47 | 24379893 | |
316 | Dimethylation | FDSKKAYRDVAWLGE CCCHHHHCCCHHHCC | 36.47 | - | |
331 | Phosphorylation | CDQGCLALAELLGWK CHHHHHHHHHHHCCH | 2.16 | - | |
338 | Acetylation | LAELLGWKKELEDLV HHHHHCCHHHHHHHH | 34.27 | 156103 | |
339 | Ubiquitination | AELLGWKKELEDLVR HHHHCCHHHHHHHHH | 62.11 | - | |
351 | Phosphorylation | LVRREHASIDAQSGA HHHHHHHCCCCCCCC | 23.94 | 22167270 | |
356 | Phosphorylation | HASIDAQSGAGVPNP HHCCCCCCCCCCCCC | 32.12 | 22167270 | |
364 | Phosphorylation | GAGVPNPSTSASPKK CCCCCCCCCCCCCCC | 41.45 | 29255136 | |
365 | Phosphorylation | AGVPNPSTSASPKKS CCCCCCCCCCCCCCC | 29.57 | 30266825 | |
366 | Phosphorylation | GVPNPSTSASPKKSP CCCCCCCCCCCCCCC | 30.96 | 23401153 | |
368 | Phosphorylation | PNPSTSASPKKSPPP CCCCCCCCCCCCCCC | 36.70 | 29255136 | |
372 | Phosphorylation | TSASPKKSPPPAKDE CCCCCCCCCCCCCCC | 49.09 | 27512957 | |
382 | Phosphorylation | PAKDEARTTEREKPQ CCCCCCCCCCCCCCC | 39.80 | 26074081 | |
383 | Phosphorylation | AKDEARTTEREKPQ- CCCCCCCCCCCCCC- | 27.73 | 26074081 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
101 | T | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
104 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
331 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
368 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
368 | S | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
368 | S | Phosphorylation | Kinase | CDK5 | Q00535 | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SIR2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-23; SER-27 AND SER-368, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-372, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-23; SER-27 AND SER-368, AND MASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25 AND SER-27, AND MASSSPECTROMETRY. |